{"id":10388,"date":"2015-12-10T09:19:29","date_gmt":"2015-12-10T09:19:29","guid":{"rendered":"http:\/\/drupal.test\/projects\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/"},"modified":"2022-07-26T12:35:14","modified_gmt":"2022-07-26T16:35:14","slug":"personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/","title":{"rendered":"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication  plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale"},"content":{"rendered":"<p>Un Canadien sur cinq \u00e9prouvera une forme ou une autre de maladie mentale au cours de sa vie. Il existe des traitements, mais chaque personne y r\u00e9agit diff\u00e9remment, en partie en raison de ses g\u00e8nes. Un test am\u00e9ricain, appel\u00e9 GeneSight, analyse les g\u00e8nes d\u2019une personne et recommande le m\u00e9dicament et la posologie les plus appropri\u00e9s parmi les 33 antid\u00e9presseurs et antipsychotiques les plus commun\u00e9ment prescrits. Des essais cliniques aux \u00c9tats\u00adUnis ont montr\u00e9 que GeneSight double les chances qu\u2019un patient r\u00e9agisse bien aux antid\u00e9presseurs.<\/p>\n<p>Plus de 100 000 patients ont re\u00e7u les tests GeneSight aux \u00c9tats\u00adUnis. AssureRx, la soci\u00e9t\u00e9 qui a mis au point GeneSight, s\u2019associe maintenant \u00e0 des chercheurs du Centre de toxicomanie et de sant\u00e9 mentale (CAMH) de Toronto pour mettre au point le test g\u00e9nomique Enhanced GeneSight (E\u00adGeneSight).<\/p>\n<p>Ce test int\u00e9grera de nouveaux marqueurs g\u00e9nomiques que des chercheurs du CAMH ont identifi\u00e9s et caract\u00e9ris\u00e9s parce qu\u2019ils sont associ\u00e9s \u00e0 des r\u00e9actions des patients aux m\u00e9dicaments psychiatriques. AssureRx Canada et CAMH valideront conjointement ces marqueurs pour d\u00e9terminer s\u2019ils peuvent pr\u00e9voir l\u2019efficacit\u00e9 et les effets secondaires de ces m\u00e9dicaments psychiatriques; les marqueurs les plus pr\u00e9dictifs seront int\u00e9gr\u00e9s \u00e0 E- GeneSight. Le test E\u00adGeneSight, lorsqu\u2019il sera lanc\u00e9 en 2017, devrait r\u00e9duire la n\u00e9cessit\u00e9 des \u00ab essais\u00aderreurs \u00bb dans les prescriptions et accro\u00eetre la probabilit\u00e9 que les patients r\u00e9agissent de mani\u00e8re optimale aux m\u00e9dicaments qui leur sont prescrits, tout en r\u00e9duisant les effets secondaires.<\/p>\n<p>Ces am\u00e9liorations feront augmenter la proportion de patients qui continuent de prendre leurs m\u00e9dicaments et am\u00e9liorent leur qualit\u00e9 de vie. Le syst\u00e8me de sant\u00e9 canadien \u00e9conomisera aussi 4 000 $ par ann\u00e9e par patient r\u00e9sistant au traitement et CAMH recevra des redevances quand le test E\u00adGeneSight se vendra \u00e0 l\u2019\u00e9chelle internationale.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un Canadien sur cinq \u00e9prouvera une forme ou une autre de maladie mentale au cours de sa vie. Il existe des traitements, mais chaque personne y r\u00e9agit diff\u00e9remment, en partie en raison de ses g\u00e8nes. Un test am\u00e9ricain, appel\u00e9 GeneSight, analyse les g\u00e8nes d\u2019une personne et recommande le m\u00e9dicament et la posologie les plus appropri\u00e9s [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[92],"genome-competitions":[210],"project-sector":[],"genome_centres":[108],"class_list":["post-10388","project","type-project","status-publish","hentry","project-categories-translation-fr","genome-competitions-programme-de-partenariats-pour-les-applications-de-la-genomique","genome_centres-ontario-genomics-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Un Canadien sur cinq \u00e9prouvera une forme ou une autre de maladie mentale au cours de sa vie. Il existe des traitements, mais chaque personne y r\u00e9agit diff\u00e9remment, en partie en raison de ses g\u00e8nes. Un test am\u00e9ricain, appel\u00e9 GeneSight, analyse les g\u00e8nes d\u2019une personne et recommande le m\u00e9dicament et la posologie les plus appropri\u00e9s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T16:35:14+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\\\/\",\"name\":\"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-10T09:19:29+00:00\",\"dateModified\":\"2022-07-26T16:35:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/","og_locale":"fr_FR","og_type":"article","og_title":"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada","og_description":"Un Canadien sur cinq \u00e9prouvera une forme ou une autre de maladie mentale au cours de sa vie. Il existe des traitements, mais chaque personne y r\u00e9agit diff\u00e9remment, en partie en raison de ses g\u00e8nes. Un test am\u00e9ricain, appel\u00e9 GeneSight, analyse les g\u00e8nes d\u2019une personne et recommande le m\u00e9dicament et la posologie les plus appropri\u00e9s [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T16:35:14+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/","url":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/","name":"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2015-12-10T09:19:29+00:00","dateModified":"2022-07-26T16:35:14+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/personnalisation-du-medicament-en-fonction-du-patient-une-medication-plus-sure-et-plus-efficace-pour\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Personnalisation du m\u00e9dicament en fonction du patient : une m\u00e9dication plus s\u00fbre et plus efficace pour les patients atteints de maladie mentale"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10388\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10388"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10388"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10388"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10388"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}